HEALTHEQUITY, INC.·4

Jun 29, 4:22 PM ET

DILLON ADRIAN T 4

4 · HEALTHEQUITY, INC. · Filed Jun 29, 2026

Research Summary

AI-generated summary of this filing

Updated

HealthEquity (HQY) Director Adrian T. Dillon Receives 2,877 RSU Award

What Happened
Adrian T. Dillon, a director of HealthEquity, Inc. (HQY), was granted 2,877 restricted stock units (RSUs) on June 25, 2026. The filing shows the units were awarded at an acquisition price of $0.00 (2,877 @ $0 = $0). These are awards (not purchases or sales) and represent future contingent rights to receive shares.

Key Details

  • Transaction date: 2026-06-25; filing date (accession): 2026-06-29 (timely filing).
  • Award: 2,877 restricted stock units; reported price: $0.00.
  • Shares owned after transaction: not specified in this filing.
  • Footnotes: F1 — each RSU converts to one share and vests in full on the earlier of June 25, 2027 or the issuer's next annual stockholder meeting in June 2027; vested shares will be delivered upon vesting. F2 — notes an option is immediately exercisable (not directly tied to the RSU award in this transaction).
  • Remarks: Power of Attorney referenced was previously filed with the SEC on Feb 5, 2024 and is incorporated by reference.

Context
RSU grants to directors are a form of non-cash compensation and do not involve an immediate cash outlay or sale of shares. Because these units vest in the future, they are routine compensation and do not by themselves indicate immediate insider buying or selling. The economic value to the director will depend on HQY’s share price at vesting.

Insider Transaction Report

Form 4
Period: 2026-06-25
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-25+2,87762,395 total
Holdings
  • Stock Option (right to buy)

    [F2]
    Exercise: $32.50Exp: 2026-09-01Common Stock (7,632 underlying)
    7,632
  • Stock Option (right to buy)

    [F2]
    Exercise: $46.40Exp: 2027-02-01Common Stock (4,837 underlying)
    4,837
  • Stock Option (right to buy)

    [F2]
    Exercise: $50.41Exp: 2028-02-01Common Stock (4,339 underlying)
    4,339
  • Stock Option (right to buy)

    [F2]
    Exercise: $63.64Exp: 2029-02-01Common Stock (3,626 underlying)
    3,626
  • Stock Option (right to buy)

    [F2]
    Exercise: $66.06Exp: 2030-02-01Common Stock (4,012 underlying)
    4,012
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person upon vesting.
  • [F2]The option is immediately exercisable.
Signature
/s/ Michael Newton , Attorney-in-Fact|2026-06-29

Documents

1 file
  • 4
    form4-06292026_080627.xmlPrimary